Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2007
05/09/2007EP1781645A1 Oxazolo-naphthyl acids as plasminogen activator inhibitor type-1(pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases
05/09/2007EP1781635A2 Potassium channel inhibitors
05/09/2007EP1781309A1 Nelumbinis semen extract for preventing and treating ischemic heart disease and pharmaceutical composition and health food containing the same
05/09/2007EP1781271A1 Arylidenes for the treatment of estrogen related receptor-alpha mediated diseases
05/09/2007EP1781270A2 Resorcinol derivatives for lowering blood pressure
05/09/2007EP1781268A1 Treatment of myocardial infarction with 11hsd1 inhibitors
05/09/2007EP1781107A2 Herbal pharmaceutical compositions for prophylaxis and/or treatment of cardiovascular diseases and the method of preparing the same
05/09/2007EP1551369A4 Combination therapy for treatment of fibrotic disorders
05/09/2007EP1446131B1 Use of specific dose of fondaparinux sodium for the treatment of acs
05/09/2007EP1383489B1 Carbamate compounds for use in preventing or treating neurodegenerative disorders
05/09/2007EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
05/09/2007EP1183245B1 Selective npy (y5) antagonists
05/09/2007EP1169058B1 Insulin-like growth factor binding protein-4 protease
05/09/2007EP1166652B1 Utilization of material containing docosapentaenoic acid
05/09/2007EP1041992A4 Hyperhydrated citicoline, process and use
05/09/2007EP1036078B1 Thienopyrimidines
05/09/2007CN1961073A Truncated DANCE, DANCE complex and method of using these
05/09/2007CN1960991A Tetrahydro-imidazo [1,5-A] pyridin derivatives as aldosterone synthase inhibitors
05/09/2007CN1960977A Quinazoline derivative
05/09/2007CN1960725A Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis
05/09/2007CN1960705A Therapeutic foam
05/09/2007CN1958584A Derivative of fibrauretine, and preparation method
05/09/2007CN1958061A Technique for preparing Chinese traditional medicine and pills in use for clearing away heart-fire, dispersing phlegm, tranquilizing the mind, and reducing pressure
05/09/2007CN1958039A Preparation of Chinese traditional medicine for treating cardiovascular disease, and cerebrovascular disease
05/09/2007CN1958034A Medication for treating cardiovascular disease
05/09/2007CN1958032A Method for preparing medication of treating angeitis
05/09/2007CN1958025A Composition of medicine for treating cerebral arteriosclerosis, and preparation method
05/09/2007CN1958024A Chinese traditional medicine for treating coronary heart disease, andina pectoris, and preparation
05/09/2007CN1958001A Medication for treating high blood pressure
05/09/2007CN1957998A Animal use compound medicament with effects of removing toxic heat, removing heat from the blood to stop bleeding, and preparation method
05/09/2007CN1957991A Extractive of fleece-flower root, composition of Chinese traditional medicine of containing the extractive, and application
05/09/2007CN1957978A Composition of medication for treating cardiovascular disease, cerebrovascular disease, preparation method and application
05/09/2007CN1957977A Composition of medication for treating cardiovascular disease, cerebrovascular disease, preparation method and application
05/09/2007CN1957975A Composition of medication for treating cardiovascular disease, cerebrovascular disease, preparation method and application
05/09/2007CN1957967A Application of pseudostellaria root for preparing medication of treating cardiovascular disease
05/09/2007CN1957964A Method for preparing extractive of Jumi
05/09/2007CN1957958A Method for preparing extractive of ginkgo leaves
05/09/2007CN1957939A Using ABL and acetylated homolog to modulate reaction of vasculitis, and treating chronic vasculitis inflammatory disease
05/09/2007CN1957935A Drop pills of seabuckthorn fruit flavone, and preparation method
05/09/2007CN1957934A Sticking film of nitroglycerin, and preparation method
05/09/2007CN1957933A Application of theanine in preparing medication of curing sequela of apoplexy or convalescent period of apoplexy
05/09/2007CN1957929A New type medication preparation of containing isosorbide dinitrate or isosorbide nitrate
05/09/2007CN1957927A Fat micro sphere preparation of triterpenoid saponin and derivative, and fabricating method
05/09/2007CN1957754A Health care powder of bitter buckwheat for three degressions, and preparation method
05/09/2007CN1314813C 虫草多肽制品及其制备方法和应用 Cordyceps polypeptide products and its preparation method and application
05/09/2007CN1314696C 2-O-(beta-D-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it
05/09/2007CN1314683C Indole derivatives or benzimidazole derivatives for modulating IKB kinase
05/09/2007CN1314674C Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase
05/09/2007CN1314429C Chinese traditional medicine for treating cardiac arrhythmia and its preparation method
05/09/2007CN1314423C Kudzuvine root containing capsule capable of regulating blood pressure and blood fat, preventing and treating cardiovascular and cerebrovascular diseases
05/09/2007CN1314417C Chinese medicine preparation for treating apoplexia and chest Bi-syndrome and its preparing method
05/09/2007CN1314416C Pile treating Chinese medicine
05/09/2007CN1314402C Drug composition containing fructus tribuli fruit total saponin and its preparation method
05/08/2007US7214800 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents
05/08/2007US7214798 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; analgesics
05/08/2007US7214778 Solvent extraction from plant
05/08/2007US7214772 Sialoadhesin family member-2 (SAF-2)
05/08/2007US7214716 Hypotensive agents; antiinflammatory agents; gastrointestinal disorders; autoimmune disease; 4-phenyl pinene derivatives
05/08/2007US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
05/08/2007US7214714 for treatment of renal diseases, cerebrovascular diseases and circulatory diseases
05/08/2007US7214712 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
05/08/2007US7214710 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
05/08/2007US7214700 Administering to a human patient an 2-oxindole-3-ylidenyl) acetic acid derivatives which modulate the activity of protein kinases and effective to treat disorders related to abnormal protein kinase activity, such as cancer
05/08/2007US7214697 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists
05/08/2007US7214689 Isoquinoline compounds
05/08/2007US7214688 Compounds
05/08/2007US7214682 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives
05/08/2007US7214680 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
05/08/2007US7214679 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease;
05/08/2007US7214677 Benzamide, heteroarylamide and reverse amides
05/08/2007US7214661 Methods of therapy with thrombin derived peptides
05/08/2007US7214659 Use of proinsulin C-peptide or a variant, derivative or fragment thereof in the manufacture of a medicament for reducing QTc interval
05/08/2007US7214495 Screening method
05/08/2007US7214393 Administering an anti-allergy composition of a wood-vinegar distilled solution, colorless and transparent
05/08/2007CA2339528C Hexahydropyrazolo[4,3-c]pyridine metabolites
05/08/2007CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
05/08/2007CA2306837C Treatment of female sexual dysfunction
05/08/2007CA2276098C Tricyclic benzo[e]isoindoles and benzo[h]isoquinolines
05/08/2007CA2207120C Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation
05/08/2007CA2185489C Cyclic adhesion inhibitors
05/03/2007WO2007050347A1 Potassium channel inhibitors
05/03/2007WO2007049798A1 Novel benzoxathiin derivative
05/03/2007WO2007049771A1 Compound containing basic group and use thereof
05/03/2007WO2007049620A1 Diagnostic agent and therapeutic agent for disease associated with hepatocyte growth factor receptor
05/03/2007WO2007049553A1 Agent for treatment of circulatory failure
05/03/2007WO2007049468A1 Cerebral infarction-preventive agent
05/03/2007WO2007049293A1 An improved process for preparation of irbesartan
05/03/2007WO2007049224A1 Novel hexahydro- or octahydro-cyclopenta[c]pyrrole derivatives
05/03/2007WO2007049089A1 Method of stimulating growth of functional blood vessels and/or regeneration of myocardium in damaged tissues
05/03/2007WO2007049088A1 Method of stimulating growth of functional blood vessels and/or regeneration of myocardium in damaged tissues
05/03/2007WO2007049085A1 Process for the preparation of sour cherry seed extract, use of the extract for the preparation of pharmaceutical compositions and pharmaceutical compositions containing said extract
05/03/2007WO2007048643A1 Novel compound
05/03/2007WO2007048510A1 Rxr agonists and antagonists, alone or in combination with ppar ligands, in the treatment of metabolic and cardiovascular diseases
05/03/2007WO2007048353A1 Pharmaceutical composition and method for neoangiogenesis/revascularization useful in treating ischemic heart diseases
05/03/2007WO2007048352A1 Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries
05/03/2007WO2007030944A3 Methods of cardioprotection using dichloroacetate in combination with an inotrope
05/03/2007WO2007025781A3 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques
05/03/2007WO2007010337A8 Use of phosphodiesterase type 5 inhibitors for the prevention and treatment of diseases or health disorders and dispensing system for said inhibitors
05/03/2007WO2007001065A3 Method for the preparation of a wet granulated drug product
05/03/2007US20070100001 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof